ArticleJournal of Cancer2020

Cyclooxygenase-2 mediates gefitinib resistance in non-small cell lung cancer through the EGFR/PI3K/AKT axis.

Qin-Fang Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.